Technical Description
This technology is an efficient carbamate-based tryptamine derivative that acts as a potent inhibitor of cholinesterase for the management of Alzheimer’s disease.
Problems Addressed
- Lacks Inhibitory Activity
- Expensive Materials
- Weak Antioxidant Properties
- Lacks Aβ Aggregation Inhibition
- Increased ROS Production
Tech Features
- Efficient Cholinesterase Inhibition
- Enhanced Multi Target Action
- Better Therapeutic Efficacy
- Enhanced Neuroprotection
- Efficient Antioxidant Property
Target Audience
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals and Healthcare Providers
- Research & Development
Tech ID: P35-1535 TRL 3 Patent Status: Published Available For Exclusive and Non-exclusive License
